NCT06378853View on ClinicalTrials.gov

Risk Factors of Postoperative Complications and Survival Rate in Pancreatic Ductal Adenocarcinoma Patients

CompletedOBSERVATIONAL

Enrollment

548

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

December 31, 2023

Study Completion Date

February 28, 2024

Conditions

Pancreatic Cancer

Interventions

OTHER

no intervention

Trial Locations (1)

Unknown

Jinling Hospital, Nanjing

All Listed Sponsors

lead

Jinling Hospital, China

OTHER

NCT06378853 - Risk Factors of Postoperative Complications and Survival Rate in Pancreatic Ductal Adenocarcinoma Patients | Biotech Hunter | Biotech Hunter